Evolvulus saxifragus
Evolvulus saxifragus · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Evolvulus saxifragus is a botanical species that has garnered scientific interest due to its unique therapeutic potential. Recent pharmacological investigations have highlighted its significant antinociceptive activities, suggesting a capacity to modulate pain signaling. A key contributor to these effects is the identified chemical compound known as Monnieriside A. This substance offers a promising pathway for managing various types of physiological distress, specifically regarding the mitigation of postoperative pain. Consequently, studying this plant provides valuable insights into developing novel natural interventions for clinical recovery.
- Synonyms
- Evolvulus Linarioides
- Common names
- Not available
- Family
- Convolvulaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Evolvulus saxifragus is a fascinating species that often presents challenges for botanists due to its taxonomic history. In many scientific records, you will find this plant listed under the synonym Evolvulus linarioides. This nomenclature overlap can sometimes cause confusion when researchers are searching for specific morphological data. Understanding these botanical connections is essential for maintaining accurate databases in plant studies. Recognizing both names ensures that the biological characteristics of the species are correctly attributed across different literature.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Evolvulus saxifragus is a unique botanical specimen that belongs to the vast kingdom Plantae. Within this diverse kingdom, the plant is specifically classified under the class Equisetopsida. It further resides in the order Solanales, showcasing its evolutionary connections to related species. The plant is a member of the genus Evolvulus, which helps botanists identify its distinct characteristics. Finally, its placement within the family Convolvulaceae highlights its structural and biological lineage.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Solanales |
| Family | Convolvulaceae |
| Genus | Evolvulus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Evolvulus saxifragus is a resilient plant species with a diverse distribution throughout the South American continent. It can be found thriving in various regions of Brazil, specifically across the Northeast and Southeast territories. Beyond the borders of Brazil, its presence extends into the southern reaches of South America. This geographical spread includes significant populations located within Paraguay. Collectively, these locations highlight the plant's ability to adapt to the different environments found across these southern regions.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Evolvulus saxifragus is characterized by its distinct growth form as a herbaceous plant. This species is entirely self-supporting, allowing it to maintain its structure within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Evolvulus saxifragus belongs to a genus that has demonstrated significant pharmacological potential in managing pain. Research into related species has highlighted the presence of bioactive compounds like Monnieriside A, which exhibits potent antinociceptive effects. In various animal models, these substances have successfully inhibited nociception during inflammatory phases without causing motor impairment. Furthermore, such compounds have proven effective in reducing mechanical allodynia associated with postoperative pain. These findings underscore the therapeutic promise held by members of the Evolvulus genus in the development of new analgesic treatments.
Compounds
Evolvulus saxifragus contains Monnieriside A, a chromone compound that has demonstrated significant therapeutic potential. Research indicates that this specific molecule can effectively promote antinociceptive effects in various models of pain. Specifically, it has been shown to inhibit nociception during the inflammatory phase without causing motor impairment in subjects. Furthermore, Monnieriside A reduces mechanical allodynia associated with both surgical incisions and inflammatory injections. These findings suggest that the compound plays a crucial role in modulating complex pain responses and inflammatory markers.
Conditions
Evolvulus saxifragus, specifically through its component Monnieriside A, effectively treats inflammatory pain in various models. It inhibits nociception during the inflammatory phase of the formalin test without causing motor impairment. Additionally, the plant treats hindpaw mechanical allodynia triggered by the intraplantar injection of Complete Freund's Adjuvant (CFA). The plant also provides relief for postoperative pain, demonstrated by its ability to treat a surgical paw incision used to simulate such conditions. These antinociceptive effects are accompanied by a reduction in IL-1β levels in the affected area.